NCT00364195View on ClinicalTrials.gov

Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

June 30, 2006

Conditions

Metastatic Breast Cancer

Interventions

DRUG

Tesmilifene (YMB1002)

Trial Locations (3)

Unknown

Clinical Hospital Center Bezanijska Kosa, Belgrade

Institute for Oncology and Radiology of Serbia (IORS), Belgrade

Institute of Oncology Sremska Kamenica, Kamenitz

Sponsors

Lead Sponsor

All Listed Sponsors

lead

YM BioSciences

INDUSTRY

NCT00364195 - Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter